News | Prostate Cancer | October 19, 2023

Added risk links back to basic anatomy 

Radiation therapy is one of the most common treatments for prostate cancer

Dr. Kiran Nandalur (left), a radiologist with Corewell Health and principal investigator of a new study showing that a simple MRI scan could predict radiation side effects for prostate cancer, reviews patient images with his colleague Dr. James Relle. 


October 19, 2023 — A new Corewell Health study suggests that men who have longer prostatic urethras, the part of the urethra that travels through the prostate, may be at a higher risk of experiencing moderate, often chronic urinary side effects after receiving radiation for prostate cancer.   

To date, researchers have struggled to determine any risk factors that could shed light on who might experience these types of side effects ahead of time. But now, a simple MRI scan and a new metric to determine urethra length could change that. 

Results, now published in the journal Academic Radiology, indicate that for every 1-centimeter increase in length of the prostatic urethra shown on the MRIs of 361 men, patients were about 60% more likely to experience issues such as having the urgency to urinate as well as needing to urinate more often. Patients with a prostatic urethra length greater than 4.6 centimeters were nearly twice as likely to develop these symptoms.   

“We believe this particular area is more exposed to the radiation doses patients receive, resulting in direct inflammation,” said Kiran Nandalur, M.D., principal investigator of the study and a radiologist at Corewell Health. “While chronic moderate urinary side effects were more problematic in approximately 28% of participants after three years, the good news is less than 3% of men experienced severe urinary side effects.”  

According to Dr. Nandalur, there are very few known risk factors for those who will experience side effects after radiation and, in his study, factors such as type of radiation or underlying medical conditions were not predictive of symptoms. He said this underscores how challenging it has been previously to assess risk factors and highlights the need for novel and innovative methods such as the use of MRI technology in prostate cancer care.  

Radiation therapy is one of the most common treatments for prostate cancer and overall, it is considered very safe. However, while radiation therapy is well tolerated by most patients, the portion of men who experience more side effects often can find their quality of life impacted for periods of time.  

“Our novel MRI metric may help patients know beforehand what their risk is in developing these symptoms and help them make better and more informed decisions on a course of treatment that optimizes quality of life,” Nandalur said.  

He added: “Doctors also can look at ways to better spare the prostatic urethra area from radiation and potentially decrease the side effects.”  

Dr. Nandalur encourages patients to be proactive in their health and with their doctors.   

“I highly recommend patients talk with their urologist or radiation oncologist about getting a prostate MRI before therapy,” he said. “It is robust in diagnosing and evaluating the extent of prostate cancer and can potentially help patients maintain a better quality of life after undergoing treatment.”  

For more information: https://corewellhealth.org/


Related Content

News | Proton Therapy

Sept. 28, 2026 — Penn Medicine and Ion Beam Applications (IBA) have formed Noventra Oncology Alliance, a new joint ...

Time September 28, 2026
arrow
News | Digital Pathology

Sept. 24, 2026 — Leica Biosystems,has added two Paige digital pathology AI-enabled products from Tempus to its Aperio AI ...

Time September 25, 2026
arrow
News | ASTRO

Sept. 22, 2026 — Leading experts in radiation therapy from the Abramson Cancer Center (ACC) of the University of ...

Time September 24, 2026
arrow
News | Molecular Imaging

Sept. 22, 2026 — Blue Earth Diagnostics, a part of the Bracco Group, has announced new research examining how precision ...

Time September 23, 2026
arrow
News | ASTRO

Sept.16, 2026 — For appropriately selected patients with muscle-invasive bladder cancer, preserving the bladder can be a ...

Time September 17, 2026
arrow
News | Radiology Imaging

Sept. 1, 2026 — Leo Cancer Care and GE HealthCare have announced that the two companies intend to work together on GE ...

Time September 11, 2026
arrow
News | ASTRO

Sept. 9, 2026 — The 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, will take place Sept. 26 to 30 ...

Time September 11, 2026
arrow
News | Radiation Oncology

Sept. 2, 2026 — Children with one of the deadliest forms of brain cancer may benefit from an additional course of ...

Time September 03, 2026
arrow
News | Radiation Therapy

Aug. 13, 2026 — An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence ...

Time August 17, 2026
arrow
News | Prostate Cancer

Aug. 13, 2026 — Artera has announced the enrollment of the first patient in its DIRECT-AI registry study, marking the ...

Time August 14, 2026
arrow
Subscribe Now